首页 | 本学科首页   官方微博 | 高级检索  
     


Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind,randomized, placebo-controlled trial
Authors:Mahmoud S. Abdallah  Esraa M. Mosalam  Ahmed Hassan  Ahmed N. Ramadan  Hend Omara-Reda  Abdel-Aziz A. Zidan  Waad A. Samman  Eman I. El-berri
Affiliation:1. Department of Clinical Pharmacy, Faculty of Pharmacy, University of Sadat City, Sadat City, Egypt;2. Department of Biochemistry, Faculty of Pharmacy, Menoufia University, Shebeen El-Kom, Egypt;3. Department of Neuropsychiatry, Faculty of Medicine, Menoufia University, Shebeen El-Kom, Egypt;4. Zoology Department, Faculty of Science, Damanhour University, Damanhour, Egypt;5. Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Medina, Saudi Arabia;6. Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt
Abstract:
Keywords:inflammatory cytokines  negative symptoms  PANSS  pentoxifylline  phosphodiesterase inhibitor  schizophrenia
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号